The watchtower for Faith, Family, and Freedom Legislation

Federal HB729: Teleabortion Prevention Act of 2025

☆ Watch
  1. Introduced
  2. Passed House
  3. Passed Senate
  4. To President
  5. Became Law

Overview

This bill would prohibit chemical (medication) abortions from being administered without a healthcare provider physically present, restricting access to remote telemedicine abortion procedures.

Law Today

The bill does not spell out the prior law, but it addresses a gap in existing FDA regulations by responding to the practice of dispensing abortion medication (mifepristone and misoprostol) without an in-person healthcare provider present.

If Passed

This bill would require a licensed healthcare provider to be physically present when a woman takes abortion medication. Currently, medication abortion can be provided via telemedicine or mail order in many states. If passed, any woman seeking a chemical abortion would need to take the medication in a medical setting with a provider on hand, eliminating remote or at-home abortion medication options.

AI-generated from the bill text — verify against the official text.

Should I support this?

  1. Strongly Oppose
  2. Likely Oppose
  3. Neutral
  4. This billLikely Support
  5. Strongly Support

Likely Support

From a Christian pro-life perspective, this bill protects developing human life by adding safeguards and professional oversight to the abortion process. It treats abortion as a serious medical matter requiring provider presence, reinforcing the value Christians place on the sanctity of life from conception.

AI assessment using F3’s editorial criteria — faith, family, and freedom. This is F3’s policy judgment; verify the provisions in the official bill text.

Likely supporters & opponents

Likely support

  • Pro-life organizations — Requiring provider presence at the time of medication administration protects the mother's health and ensures medical oversight of a serious medical procedure.

Likely opposition

  • Medical associations and abortion-rights groups — This requirement creates barriers to access, contradicts FDA evidence that medication abortion is safe when taken at home, and increases costs and logistical burdens on women seeking a legal medical service.
  • Telemedicine advocacy organizations — The requirement reverses decades of progress in expanding remote healthcare access and imposes an unconstitutional or undue burden on a woman's right to abortion.

AI-inferred typical positions based on the bill’s substance — general stakeholder categories, not confirmed endorsements.

Official summary

To prohibit chemical abortions performed without the presence of a healthcare provider, and for other purposes.

Sponsors

  • Mark Harris (R)
  • Andrew Clyde (R)
  • Robert Aderholt (R)
  • Daniel Webster (R)
  • Brandon Gill (R)
  • Mary Miller (R)
  • Michael Cloud (R)
  • Harriet Hageman (R)
  • Warren Davidson (R)
  • Robert Onder (R)
  • Keith Self (R)
  • Randy Weber (R)
  • Barry Moore (R)
  • Tracey Mann (R)
  • Pat Harrigan (R)
  • Andy Biggs (R)
  • Richard Hudson (R)
  • Sheri Biggs (R)
  • Robert Latta (R)

Status timeline

  1. 2025-01-24Referred to the House Committee on the Judiciary.H
  2. 2025-01-24Introduced in HouseH

H = House · S = Senate · A = Assembly